Opposition to cannabis legalization rests on a broad set of arguments that draw from public health data, road safety statistics, environmental science, and social research. Whether or not one finds these arguments decisive, they are grounded in real findings: legalization has been linked to increases in traffic fatalities, emergency department visits among children, and cardiovascular events among heavy users. The case against legalization is not a single claim but a web of concerns, and the evidence behind many of them has grown stronger in recent years as researchers gain access to data from jurisdictions that have already legalized.
The Mental Health Case
The most frequently cited health argument against legalization centers on psychosis. A multisite case-control study across Europe found that daily use of high-potency cannabis carried more than four times the odds of a psychotic disorder compared with people who had never used it.1The Lancet Psychiatry. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study An earlier London-based study reported that among people experiencing a first psychotic episode, 78% had been using high-potency cannabis, compared with 37% of healthy controls.2PubMed Central. High-potency cannabis and the risk of psychosis And a longitudinal cohort study tracking young people from age 16 found that those who used high-potency cannabis in their teens were roughly twice as likely to develop new psychotic experiences in their early twenties.3PubMed Central. Incident psychotic experiences following self-reported use of high-potency cannabis: Results from a longitudinal cohort study
Opponents of legalization argue that these findings matter more in a legal market because legalization tends to normalize use, increase availability, and push potency upward. The psychosis link is dose-dependent: it is not just whether someone uses cannabis, but how often and how strong the product is. If a legal regime makes daily use of high-potency products easier, the population-level burden of psychotic disorders could grow.
Beyond psychosis, an umbrella review of the evidence on cannabis and suicidality found a consistent positive association between cannabis use and both suicidal ideation and suicide attempts across the general population, adolescents, military veterans, and people with mood disorders. The association was worse with younger age of first use, longer duration of use, and heavier consumption.4PubMed Central. Suicidality risk after using cannabis and cannabinoids: An umbrella review Critics of legalization see this as a reason to keep barriers to access high, especially for vulnerable populations.
What It Does to Adolescent Brains
A recurring concern is that legalization will inevitably increase youth access, whether through loosened social norms, household supply, or diversion from legal buyers. The cognitive stakes for teenagers are not trivial. A large New Zealand cohort study following more than a thousand people from birth to age 38 found that persistent cannabis dependence was associated with declines in IQ, with the steepest drops in executive functioning and processing speed among those who started weekly use before age 18.5PubMed Central. Effects of Cannabis on the Adolescent Brain
A separate population-based study directly comparing cannabis and alcohol found that cannabis had lasting negative effects on inhibitory control and working memory in adolescents, and that these effects were more pronounced than those observed for alcohol.6PubMed. A Population-Based Analysis of the Relationship Between Substance Use and Adolescent Cognitive Development That comparison is striking because alcohol is already legal and widely regarded as harmful to young brains. If cannabis has a bigger cognitive footprint on teenagers, the argument goes, expanding access through legalization is moving in the wrong direction.
The downstream effects on education are measurable. Research estimating the long-term consequences of adolescent marijuana use found a large reduction in the likelihood of completing a college or graduate degree by the time those users reached their mid-thirties to early forties.7PubMed. The effect of marijuana use in adolescence on college and graduate degree attainment A study tracking trajectories of use from ages 15 to 25 found that frequent users had the lowest high school grades, the most conduct problems, and the lowest rates of enrollment in postsecondary education. Even occasional users, while similar to abstainers in high school performance, were more likely to delay enrollment or drop out.8PubMed Central. Trajectories of marijuana use in youth ages 15-25: implications for postsecondary education experiences
Addiction Is More Common Than People Think
A persistent myth holds that cannabis is not addictive. A meta-analysis of population surveys puts the lifetime prevalence of cannabis use disorder at roughly 7%, and the past-year prevalence at about 2.5%.9PubMed Central. Prevalence of Cannabis Use Disorder: A Meta-Analysis of Population Surveys Those percentages are not small when applied to the roughly 40% of the population that has tried cannabis at some point. The implication is that a meaningful fraction of users develop a clinically recognized pattern of problematic use, with difficulty cutting back, withdrawal symptoms, and interference with daily life.
Opponents of legalization point out that as a market matures and potency climbs, the share of users who develop dependence could rise. The legal alcohol market offers a cautionary parallel: easy access and social normalization are associated with higher per capita consumption, and higher consumption is the strongest predictor of dependence at the population level.
Rising Potency Makes Historical Comparisons Misleading
One reason the anti-legalization case has gotten sharper over time is that the cannabis on today’s market bears little resemblance to what was available a few decades ago. Data from Drug Enforcement Administration seizures show that average THC content in herbal cannabis products roughly tripled from around 4% in 1995 to nearly 14% in 2019.10Frontiers in Pharmacology. Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot Concentrates can be far higher. A separate analysis covering 2008 to 2017 found that mean THC concentration in the U.S. market rose from about 9% to 17%, while the ratio of THC to CBD climbed from 23 to over 100.11PubMed. New trends in cannabis potency in USA and Europe during the last decade (2008-2017)
This matters because most of the harms described throughout this article are dose-dependent. The psychosis risk, the cardiovascular risk, the addiction potential, the cognitive effects on adolescents: all are tied to how much THC a person consumes. Legalization skeptics argue that the product being legalized today is fundamentally different from the one many people picture when they think of cannabis, and that regulations have struggled to keep pace with potency escalation in legal markets.
Traffic Safety After Legalization
Road safety has become one of the most data-rich arguments against legalization. A study examining crash data across U.S. states found that legalization of recreational marijuana was associated with a roughly 6.5% increase in injury crash rates and a 4.1% increase in fatal crash rates.12PubMed Central. Changes in Traffic Crash Rates After Legalization of Marijuana: Results by Crash Severity A separate analysis using more recent statistical methods found slightly larger effects, with increases of about 2.2 additional fatalities per billion vehicle miles traveled after retail sales began, and with states that legalized earlier seeing bigger increases than latecomers.13International Journal of Drug Policy. Revisiting the effect of recreational marijuana on traffic fatalities
Unlike alcohol, there is no reliable roadside equivalent to a breathalyzer for cannabis impairment. THC can be detected in blood for days after use, and its presence does not reliably indicate current impairment the way blood alcohol concentration does. This enforcement gap is a practical concern: even if impaired driving remains illegal, police and prosecutors have limited tools to prove it in real time. For opponents of legalization, this means the traffic safety cost is baked into the policy itself, not something regulation can easily fix.
Children and Edibles
Legal cannabis markets have introduced a range of edible products, many of which come in forms that look appealing to children: gummies, chocolates, and brightly colored candies. Canadian data from 2015 to 2021 showed that pediatric emergency visits for cannabis-related poisoning rose sharply after legalization, with an average annual increase of nearly 100% in Ontario. Almost half of all pediatric edible-related events involved gummy products, and about 88% of those events were attributed to accidental ingestion because of poor storage or easy access.14PubMed Central. Trends in cannabis-related emergency department visits and hospitalizations among children aged 0–11 years in Canada from 2015 to 2021: spotlight on cannabis edibles In the United States, an estimated 1,245 pediatric emergency visits related to unintentional marijuana poisoning were documented, with most involving edible products and most resulting in hospital admission.15PubMed. Pediatric Poisonings Associated With Ingestion of Marijuana Products
Proponents of legalization counter that child-resistant packaging and labeling requirements can address this. Opponents respond that the data from jurisdictions with those regulations already in place suggests the measures have not been sufficient. Cannabis edibles present a unique challenge because the product itself, a gummy bear or chocolate bar, is indistinguishable from candy to a young child.
Cardiovascular and Other Physical Harms
The cardiovascular risks of cannabis have received increasing attention. A systematic review and meta-analysis estimated that cannabis use was associated with about a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke, and roughly double the risk of cardiovascular death.16PubMed. Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis A large cross-sectional U.S. study found that daily cannabis use was associated with increased odds of heart attack and stroke, and that this held true even among people who had never smoked tobacco.17PubMed Central. Association of Cannabis Use With Cardiovascular Outcomes Among US Adults Laboratory research has also shown that even brief exposure to secondhand marijuana smoke impairs blood vessel function for at least 90 minutes, longer than the comparable impairment from tobacco secondhand smoke.18PubMed Central. One Minute of Marijuana Secondhand Smoke Exposure Substantially Impairs Vascular Endothelial Function
Another physical consequence that has emerged alongside legalization is cannabinoid hyperemesis syndrome, a condition involving repeated bouts of severe nausea and vomiting in heavy, long-term users. In Nevada, emergency visits for the syndrome roughly doubled after recreational sales began.19PubMed Central. Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis A follow-up study found that a quarter of patients who came to the emergency department with the syndrome returned with the same problem within three months, because most went back to their pre-visit cannabis use within days.20PubMed. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department The condition is not life-threatening in most cases, but it consumes emergency resources and signals that heavy use, which legalization tends to facilitate, carries its own clinical costs.
Pregnancy and Fetal Development
A growing body of research raises concerns about cannabis use during pregnancy. A meta-analysis found that in utero cannabis exposure was associated with lower birth weight, with exposed infants weighing on average about 109 grams less than unexposed infants, and roughly 77% higher odds of being classified as low birth weight.21PubMed Central. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis A large population-based study from Ontario found that maternal cannabis use was associated with a higher incidence of autism spectrum disorder in offspring, with a fully adjusted hazard ratio of about 1.5, though the authors emphasized the likelihood of residual confounding.22Nature Medicine. Maternal cannabis use in pregnancy and child neurodevelopmental outcomes A systematic review identified additional associations with sleep disturbances, memory problems, and hyperactivity in exposed children.23European Journal of Midwifery. Cannabis use during pregnancy and its effect on the fetus, newborn and later childhood: A systematic review
Opponents of legalization are troubled by survey data showing that cannabis use among pregnant women has been rising in jurisdictions where it has been legalized, in part because some women perceive a legal product as safer than an illegal one. The evidence above suggests that perception is misguided.
Workplace Safety and Productivity
The workplace argument against legalization is more nuanced than it might seem. A longitudinal study of Canadian workers found that using cannabis outside the workplace did not significantly increase the risk of a workplace injury. Using cannabis at work, however, was associated with roughly double the risk.24PubMed Central. Workplace and non-workplace cannabis use and the risk of workplace injury: Findings from a longitudinal study of Canadian workers A scoping review of systematic reviews noted that adverse effects associated with medicinal cannabis use, including decreased alertness, slower reaction times, and reduced ability to operate machinery, could increase workplace risks across a range of occupations.25PubMed Central. Medicinal Cannabis and Implications for Workplace Health and Safety: Scoping Review of Systematic Reviews
From the employer’s perspective, legalization creates a regulatory headache. Drug testing policies that once served as a proxy for impairment become less useful when off-duty use is legal, and there is no equivalent of a blood alcohol limit for cannabis that reliably measures current impairment. Industries where safety is paramount, such as construction, transportation, and healthcare, face the challenge of maintaining fitness-for-duty standards without a clear biological marker to enforce them.
The Black Market Does Not Disappear
One of the strongest promises of legalization has always been that it would undercut the illegal market. In practice, this has proven harder than expected. Research has found that illicit markets persist in every jurisdiction where recreational cannabis has been legalized, often because the regulated product is more expensive due to taxes and compliance costs.26Preventive Medicine Reports. Legalization of recreational cannabis: Facilitators and barriers to switching from an illegal to a legal source A study of regulatory frameworks found that many legalized states have failed to establish rules that effectively keep both producers and consumers in the legal market.27PDXScholar. Effects of Regulation Intensity on Marijuana Black Market After Legalization
This undermines a central selling point of legalization. If the illegal market remains robust, the promised reductions in criminal activity and the expected tax revenue both fall short. A cost-benefit analysis comparing the status quo with a legalized-and-regulated model found no substantive difference in the net social benefit between the two approaches. Adding government revenue tipped the balance slightly toward legalization, but the level of uncertainty around that result also increased.28PLOS ONE. Cost Benefit Analysis of Two Policy Options for Cannabis: Status Quo and Legalisation
Environmental Costs of Commercial Cultivation
An argument that often gets overlooked in the legalization debate is the environmental footprint of commercial cannabis farming. A narrative review found that both indoor and outdoor cannabis cultivation are water-intensive, leading to water pollution and stream diversion that can damage aquatic ecosystems. Indoor cultivation is especially energy-hungry, driven by heating, ventilation, air conditioning, and lighting systems, and that energy consumption translates directly into greenhouse gas emissions.29PubMed Central. A narrative review on environmental impacts of cannabis cultivation A life cycle assessment of the Canadian cannabis industry confirmed that indoor cultivation, while high-yielding, relies heavily on energy-intensive systems across multiple environmental dimensions including carbon footprint, fossil fuel use, and water pollution.30Resources, Conservation and Recycling. Greener green: The environmental impacts of the Canadian cannabis industry
A review of peer-reviewed research identified six documented environmental impact pathways from cannabis cultivation: land-cover change, water use, pesticide use, energy use, air pollution, and water pollution from consumption.31Environmental Science & Technology Letters. Cannabis and the Environment: What Science Tells Us and What We Still Need to Know Legalization has dramatically scaled up cultivation, particularly indoors, and the industry’s environmental footprint grows with it.
Product Safety and Contaminants
Legalization proponents often argue that regulation makes cannabis safer by imposing quality standards. There is some truth to this, but the picture is incomplete. A comparative study of legal and illegal cannabis in Canada found that while illegal products were far worse on most contamination measures (55% exceeded aerobic plate count limits versus 20% of legal products, and 94% of illegal samples contained pesticides), legal products were not clean across the board. Some legal samples exceeded U.S. Pharmacopeia inhalation limits for certain metals, and legal products showed higher chromium concentrations than illegal ones.32PubMed Central. Comparative analysis of metals, pesticides, mycotoxins, microbial contaminants and THC potency in illegal and regulated cannabis inflorescences in Canada A broader review of cannabis contaminants noted that the direct human toxicity of common contaminants, including microbes, heavy metals, and pesticides, remains poorly quantified, with potential effects ranging from infection to cancer to reproductive harm.33PubMed Central. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects
The Gateway Question and Cross-Substance Effects
The idea that cannabis is a “gateway drug” is often dismissed as outdated, but the research is more nuanced than either side tends to acknowledge. A review in the context of the opioid epidemic concluded that cannabis use in some people can introduce genuine new risk for starting opioid use and developing opioid use disorder.34PubMed Central. Cannabis as a Gateway Drug for Opioid Use Disorder Twin studies have suggested that the co-occurrence of cannabis use and other drug use is driven by a mix of shared genetic vulnerabilities and causal gateway-type influences, rather than one mechanism alone.35Psychological Medicine. Contrasting models of genetic co-morbidity for cannabis and other illicit drugs in adult Australian twins
A systematic review of how cannabis policy changes affect other substance use found a complicated pattern: alcohol use may decrease after medical legalization, suggesting people substitute cannabis for alcohol. But alcohol use among young adults may increase after recreational legalization, suggesting co-consumption rather than substitution.36PubMed Central. Impacts of Global Cannabis Policy Changes on Substance Use: A Systematic Review of Quasi-Experimental Studies If recreational legalization drives young adults to use more of both cannabis and alcohol, the combined health burden could exceed what either substance would produce alone.
Crime Near Dispensaries
Community resistance to cannabis retail often focuses on the belief that dispensaries attract crime. The evidence on this is mixed in ways that are worth understanding. A study in Sacramento found no association between dispensary density and violent or property crime rates.37PubMed Central. Exploring the ecological association between crime and medical marijuana dispensaries A more granular analysis in Long Beach, California, found that dispensary density was unrelated to crime in the immediate local area but was positively associated with violent and property crime in adjacent areas.38PubMed Central. A micro-temporal geospatial analysis of medical marijuana dispensaries and crime in Long Beach, California The spillover effect is modest, but it suggests that the impact of dispensaries on neighborhood safety is not zero and may depend heavily on local context, zoning, and enforcement.